60 results on '"Lanz RB"'
Search Results
2. Transcriptional coactivation of NRF2 signaling in cardiac fibroblasts promotes resistance to oxidative stress.
- Author
-
McClendon LK, Lanz RB, Panigrahi A, Gomez K, Bolt MJ, Liu M, Stossi F, Mancini MA, Dacso CC, Lonard DM, and O'Malley BW
- Subjects
- Animals, Apoptosis drug effects, Transcriptional Activation drug effects, Fibrosis, Heme Oxygenase-1 metabolism, Heme Oxygenase-1 genetics, Rats, Cell Survival drug effects, Cell Survival genetics, Mice, NF-E2-Related Factor 2 metabolism, Oxidative Stress drug effects, Fibroblasts metabolism, Signal Transduction drug effects, Myocardium metabolism, Myocardium pathology
- Abstract
We recently discovered that steroid receptor coactivators (SRCs) SRCs-1, 2 and 3, are abundantly expressed in cardiac fibroblasts (CFs) and their activation with the SRC small molecule stimulator MCB-613 improves cardiac function and dramatically lowers pro-fibrotic signaling in CFs post-myocardial infarction. These findings suggest that CF-derived SRC activation could be beneficial in the mitigation of chronic heart failure after ischemic insult. However, the cardioprotective mechanisms by which CFs contribute to cardiac pathological remodeling are unclear. Here we present studies designed to identify the molecular and cellular circuitry that governs the anti-fibrotic effects of an MCB-613 derivative, MCB-613-10-1, in CFs. We performed cytokine profiling and whole transcriptome and proteome analyses of CF-derived signals in response to MCB-613-10-1. We identified the NRF2 pathway as a direct MCB-613-10-1 therapeutic target for promoting resistance to oxidative stress in CFs. We show that MCB-613-10-1 promotes cell survival of anti-fibrotic CFs exposed to oxidative stress by suppressing apoptosis. We demonstrate that an increase in HMOX1 expression contributes to CF resistance to oxidative stress-mediated apoptosis via a mechanism involving SRC co-activation of NRF2, hence reducing inflammation and fibrosis. We provide evidence that MCB-613-10-1 acts as a protectant against oxidative stress-induced mitochondrial damage. Our data reveal that SRC stimulation of the NRF2 transcriptional network promotes resistance to oxidative stress and highlights a mechanistic approach toward addressing pathologic cardiac remodeling., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis.
- Author
-
Chadchan SB, Popli P, Liao Z, Andreas E, Dias M, Wang T, Gunderson SJ, Jimenez PT, Lanza DG, Lanz RB, Foulds CE, Monsivais D, DeMayo FJ, Yalamanchili HK, Jungheim ES, Heaney JD, Lydon JP, Moley KH, O'Malley BW, and Kommagani R
- Subjects
- Animals, Female, Humans, Mice, Endometrium metabolism, Estrogens metabolism, Progesterone metabolism, Receptors, Progesterone genetics, Receptors, Progesterone metabolism, Steroids metabolism, Endometriosis genetics, Endometriosis metabolism, Neoplasm Proteins metabolism, Receptors, Steroid genetics, Receptors, Steroid metabolism
- Abstract
Cellular responses to the steroid hormones, estrogen (E2), and progesterone (P4) are governed by their cognate receptor's transcriptional output. However, the feed-forward mechanisms that shape cell-type-specific transcriptional fulcrums for steroid receptors are unidentified. Herein, we found that a common feed-forward mechanism between GREB1 and steroid receptors regulates the differential effect of GREB1 on steroid hormones in a physiological or pathological context. In physiological (receptive) endometrium, GREB1 controls P4-responses in uterine stroma, affecting endometrial receptivity and decidualization, while not affecting E2-mediated epithelial proliferation. Of mechanism, progesterone-induced GREB1 physically interacts with the progesterone receptor, acting as a cofactor in a positive feedback mechanism to regulate P4-responsive genes. Conversely, in endometrial pathology (endometriosis), E2-induced GREB1 modulates E2-dependent gene expression to promote the growth of endometriotic lesions in mice. This differential action of GREB1 exerted by a common feed-forward mechanism with steroid receptors advances our understanding of mechanisms that underlie cell- and tissue-specific steroid hormone actions., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
4. SOX7 deficiency causes ventricular septal defects through its effects on endocardial-to-mesenchymal transition and the expression of Wnt4 and Bmp2.
- Author
-
Hernández-García A, Pendleton KE, Kim S, Li Y, Kim BJ, Zaveri HP, Jordan VK, Berry AM, Ljungberg MC, Chen R, Lanz RB, and Scott DA
- Subjects
- Animals, Mice, Endocardium metabolism, Heart, Myocardium metabolism, SOXF Transcription Factors metabolism, Heart Defects, Congenital genetics, Heart Septal Defects, Ventricular genetics, Heart Septal Defects, Ventricular metabolism
- Abstract
SOX7 is a transcription factor-encoding gene located in a region on chromosome 8p23.1 that is recurrently deleted in individuals with ventricular septal defects (VSDs). We have previously shown that Sox7-/- embryos die of heart failure around E11.5. Here, we demonstrate that these embryos have hypocellular endocardial cushions with severely reduced numbers of mesenchymal cells. Ablation of Sox7 in the endocardium also resulted in hypocellular endocardial cushions, and we observed VSDs in rare E15.5 Sox7flox/-;Tie2-Cre and Sox7flox/flox;Tie2-Cre embryos that survived to E15.5. In atrioventricular explant studies, we showed that SOX7 deficiency leads to a severe reduction in endocardial-to-mesenchymal transition (EndMT). RNA-seq studies performed on E9.5 Sox7-/- heart tubes revealed severely reduced Wnt4 transcript levels. Wnt4 is expressed in the endocardium and promotes EndMT by acting in a paracrine manner to increase the expression of Bmp2 in the myocardium. Both WNT4 and BMP2 have been previously implicated in the development of VSDs in individuals with 46,XX sex reversal with dysgenesis of kidney, adrenals and lungs (SERKAL) syndrome and in individuals with short stature, facial dysmorphism and skeletal anomalies with or without cardiac anomalies 1 (SSFSC1) syndrome, respectively. We now show that Sox7 and Wnt4 interact genetically in the development of VSDs through their additive effects on endocardial cushion development with Sox7+/-;Wnt4+/- double heterozygous embryos having hypocellular endocardial cushions and perimembranous and muscular VSDs not seen in their Sox7+/- and Wnt4+/- littermates. These results provide additional evidence that SOX7, WNT4 and BMP2 function in the same pathway during mammalian septal development and that their deficiency can contribute to the development of VSDs in humans., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
5. Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion.
- Author
-
Han SJ, Jain P, Gilad Y, Xia Y, Sung N, Park MJ, Dean AM, Lanz RB, Xu J, Dacso CC, Lonard DM, and O'Malley BW
- Subjects
- Animals, Female, Male, Mice, Ligands, Mice, Knockout, T-Lymphocytes, Regulatory, Tamoxifen pharmacology, Breast Neoplasms, Mammary Neoplasms, Animal, Nuclear Receptor Coactivator 3 genetics
- Abstract
Steroid receptor coactivator 3 (SRC-3) is most strongly expressed in regulatory T cells (Tregs) and B cells, suggesting that it plays an important role in the regulation of Treg function. Using an aggressive E0771 mouse breast cell line syngeneic immune-intact murine model, we observed that breast tumors were "permanently eradicated" in a genetically engineered tamoxifen-inducible Treg-cell-specific SRC-3 knockout (KO) female mouse that does not possess a systemic autoimmune pathological phenotype. A similar eradication of tumor was noted in a syngeneic model of prostate cancer. A subsequent injection of additional E0771 cancer cells into these mice showed continued resistance to tumor development without the need for tamoxifen induction to produce additional SRC-3 KO Tregs. SRC-3 KO Tregs were highly proliferative and preferentially infiltrated into breast tumors by activating the chemokine (C-C motif) ligand (Ccl) 19/Ccl21/chemokine (C-C motif) receptor (Ccr)7 signaling axis, generating antitumor immunity by enhancing the interferon-γ/C-X-C motif chemokine ligand (Cxcl) 9 signaling axis to facilitate the entrance and function of effector T cells and natural killer cells. SRC-3 KO Tregs also show a dominant effect by blocking the immune suppressive function of WT Tregs. Importantly, a single adoptive transfer of SRC-3 KO Tregs into wild-type E0771 tumor-bearing mice can completely abolish preestablished breast tumors by generating potent antitumor immunity with a durable effect that prevents tumor reoccurrence. Therefore, treatment with SRC-3-deleted Tregs represents an approach to completely block tumor growth and recurrence without the autoimmune side effects that typically accompany immune checkpoint modulators.
- Published
- 2023
- Full Text
- View/download PDF
6. Polyploid giant cancer cells and ovarian cancer: new insights into mitotic regulators and polyploidy†.
- Author
-
Richards JS, Candelaria NR, and Lanz RB
- Subjects
- Animals, Female, Humans, Mice, Mitosis, Giant Cells physiology, Ovarian Neoplasms genetics, Polyploidy
- Abstract
Current first-line treatment of patients with high-grade serous ovarian cancer (HGSOC) involves the use of cytotoxic drugs that frequently lead to recurrent tumors exhibiting increased resistance to the drugs and poor patient survival. Strong evidence is accumulating to show that HGSOC tumors and cell lines contain a subset of cells called polyploidy giant cancer cells (PGCCs) that act as stem-like, self-renewing cells. These PGCCs appear to play a key role in tumor progression by generating drug-resistant progeny produced, in part, as a consequence of utilizing a modified form of mitosis known as endoreplication. Thus, developing drugs to target PGCCs and endoreplication may be an important approach for reducing the appearance of drug-resistant progeny. In the review, we discuss newly identified regulatory factors that impact mitosis and which may be altered or repurposed during endoreplication in PGCCs. We also review recent papers showing that a single PGCC can give rise to tumors in vivo and spheroids in culture. To illustrate some of the specific features of PGCCs and factors that may impact their function and endoreplication compared to mitosis, we have included immunofluorescent images co-localizing p53 and specific mitotic regulatory, phosphoproteins in xenografts derived from commonly used HGSOC cell lines., (© The Author(s) 2021. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
7. Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
- Author
-
Ding Y, Liu Y, Lee DK, Tong Z, Yu X, Li Y, Xu Y, Lanz RB, O'Malley BW, and Xu J
- Subjects
- Animals, Breast Neoplasms metabolism, Breast Neoplasms pathology, Carcinoma, Intraductal, Noninfiltrating metabolism, Carcinoma, Intraductal, Noninfiltrating secondary, Cell Line, Tumor, Cell Lineage genetics, Cell Lineage immunology, Cell Proliferation, Cell Transformation, Neoplastic, Estrogen Receptor alpha metabolism, Female, GATA3 Transcription Factor genetics, GATA3 Transcription Factor metabolism, Hepatocyte Nuclear Factor 3-alpha genetics, Hepatocyte Nuclear Factor 3-alpha metabolism, Humans, Lung Neoplasms metabolism, Lung Neoplasms secondary, Mice, Mitogen-Activated Protein Kinase 1 genetics, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 genetics, Mitogen-Activated Protein Kinase 3 metabolism, Neoplasm Invasiveness, Promoter Regions, Genetic, Receptor, ErbB-2 metabolism, Signal Transduction, Tumor Burden, Xenograft Model Antitumor Assays, Breast Neoplasms genetics, Carcinoma, Intraductal, Noninfiltrating genetics, Estrogen Receptor alpha genetics, Gene Expression Regulation, Neoplastic, Lung Neoplasms genetics, Receptor, ErbB-2 genetics
- Abstract
HER2-positive (HER2
+ ) breast cancers (BrCs) contain approximately equal numbers of ERα+ HER2+ and ERα- HER2+ cases. An enduring obstacle is the unclear cell lineage-related characteristics of these BrCs. Although ERα+ HER2+ BrCs could lose ERα to become ERα- HER2+ BrCs, direct evidence is missing. To investigate ERα dependencies and their implications during BrC growth and metastasis, we generated ERαCre RFP-T mice that produce an RFP-marked ERα+ mammary gland epithelial cell (MGEC) lineage. RCAS virus-mediated expression of Erbb2, a rodent Her2 homolog, first produced comparable numbers of ERα+ RFP+ Erbb2+ and ERα- RFP- Erbb2+ MGECs. Early hyperplasia developed mostly from ERα+ RFP+ Erbb2+ cells and ERα- RFP- Erbb2+ cells in these lesions were rare. The subsequently developed ductal carcinomas in situ had 64% slow-proliferating ERα+ RFP+ Erbb2+ cells, 15% fast-proliferating ERα- RFP+ Erbb2+ cells derived from ERα+ RFP+ Erbb2+ cells, and 20% fast-proliferating ERα- RFP- Erbb2+ cells. The advanced tumors had mostly ERα- RFP+ Erbb2+ and ERα- RFP- Erbb2+ cells and only a very small population of ERα+ RFP+ Erbb2+ cells. In ERα- RFP+ Erbb2+ cells, GATA3 and FoxA1 decreased expression and ERα promoter regions became methylated, consistent with the loss of ERα expression. Lung metastases consisted of mostly ERα- RFP+ Erbb2+ cells, a few ERα- RFP- Erbb2+ cells, and no ERα+ RFP+ Erbb2+ cells. The high metastatic capacity of ERα- RFP+ Erbb2+ cells was associated with ERK1/2 activation. These results show that the slow-proliferating, nonmetastatic ERα+ RFP+ Erbb2+ cells progressively lose ERα during tumorigenesis to become fast-proliferating, highly metastatic ERα- RFP+ Erbb2+ cells. The ERα- Erbb2+ BrCs with an ERα+ origin are more aggressive than those ERα- Erbb2+ BrCs with an ERα- origin, and thus, they should be distinguished and treated differently in the future., Competing Interests: The authors declare no competing interest.- Published
- 2021
- Full Text
- View/download PDF
8. Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms.
- Author
-
Wetendorf M, Li R, Wu SP, Liu J, Creighton CJ, Wang T, Janardhan KS, Willson CJ, Lanz RB, Murphy BD, Lydon JP, and DeMayo FJ
- Subjects
- Animals, Cell Proliferation genetics, Disease Models, Animal, Estradiol blood, Estradiol metabolism, Female, Hormones blood, Humans, Mice, Knockout, Mice, Transgenic, Microscopy, Fluorescence, Ovarian Neoplasms metabolism, Progesterone blood, Progesterone metabolism, Receptors, Progesterone metabolism, Gene Expression Profiling methods, Hormones metabolism, Ovarian Neoplasms genetics, Receptors, Progesterone genetics, Transcriptome genetics
- Abstract
Differences in the relative abundances of the progesterone receptor (PGR) isoforms PGRA and PGRB are often observed in women with reproductive tract cancers. To assess the importance of the PGR isoform ratio in the maintenance of the reproductive tract, we generated mice that overexpress PGRA or PGRB in all PGR-positive tissues. Whereas few PGRA-overexpressing mice developed reproductive tract tumors, all PGRB-overexpressing mice developed ovarian neoplasms that were derived from ovarian luteal cells. Transcriptomic analyses of the ovarian tumors from PGRB-overexpressing mice revealed enhanced AKT signaling and a gene expression signature similar to those of human ovarian and endometrial cancers. Treating PGRB-overexpressing mice with the PGR antagonist RU486 stalled tumor growth and decreased the expression of cell cycle-associated genes, indicating that tumor growth and cell proliferation were hormone dependent in addition to being isoform dependent. Analysis of the PGRB cistrome identified binding events at genes encoding proteins that are critical regulators of mitotic phase entry. This work suggests a mechanism whereby an increase in the abundance of PGRB relative to that of PGRA drives neoplasia in vivo by stimulating cell cycling., (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
- Published
- 2020
- Full Text
- View/download PDF
9. Early growth response 1 transcriptionally primes the human endometrial stromal cell for decidualization.
- Author
-
Szwarc MM, Hai L, Gibbons WE, Mo Q, Lanz RB, DeMayo FJ, and Lydon JP
- Subjects
- Animals, Cells, Cultured, Decidua metabolism, Early Growth Response Protein 1 genetics, Embryo Implantation, Endometrium metabolism, Female, Gene Knockdown Techniques, Humans, Mice, Pregnancy, Stromal Cells metabolism, Transcriptional Activation, Decidua cytology, Early Growth Response Protein 1 metabolism, Endometrium cytology, Stromal Cells cytology
- Abstract
Mouse studies support a role for endometrial early growth response 1 (EGR1) in uterine receptivity and decidualization, which are processes controlled by estrogen and progesterone. However, the importance of this transcription factor in similar cellular processes in human is unclear. Analysis of clinical samples indicate that endometrial EGR1 levels are decreased in the endometrium of women with recurrent implantation failure, suggesting that tight control of EGR1 levels are necessary for normal endometrial function. Therefore, we used siRNA-mediated knockdown of EGR1 expression in cultured human endometrial stromal cells (hESCs) to assess the functional role of EGR1 in hESC decidualization. Protein expression studies revealed that EGR1 is highly expressed in pre-decidual hESCs. However, EGR1 protein levels rapidly decrease following administration of an established deciduogenic hormone stimulus containing estradiol, medroxyprogesterone acetate, and cyclic adenosine monophosphate. Intriguingly, EGR1 knockdown in pre-decidual hESCs blocks the ability of these cells to decidualize later, indicating that EGR1 is required to transcriptionally program pre-decidual hESCs for decidualization. Support for this proposal comes from the analysis of transcriptome and cistrome datasets, which shows that EGR1 target genes are primarily involved in transcriptional regulation, cell signaling, and proliferation. Collectively, our studies provide translational support for an evolutionary conserved role for human endometrial stromal EGR1 in the early events of pregnancy establishment., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
10. FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation.
- Author
-
Vasquez YM, Wang X, Wetendorf M, Franco HL, Mo Q, Wang T, Lanz RB, Young SL, Lessey BA, Spencer TE, Lydon JP, and DeMayo FJ
- Subjects
- Animals, Cell Nucleus metabolism, Cell Polarity genetics, Cell Polarity physiology, Decidua physiology, Endometrium cytology, Female, Forkhead Box Protein O1 deficiency, Gene Expression Profiling, Humans, Mice, Mice, Knockout, Pregnancy, Receptors, Progesterone deficiency, Signal Transduction, Embryo Implantation genetics, Embryo Implantation physiology, Endometrium metabolism, Forkhead Box Protein O1 genetics, Forkhead Box Protein O1 metabolism, Receptors, Progesterone genetics, Receptors, Progesterone metabolism
- Abstract
Successful embryo implantation requires a receptive endometrium. Poor uterine receptivity can account for implantation failure in women who experience recurrent pregnancy loss or multiple rounds of unsuccessful in vitro fertilization cycles. Here, we demonstrate that the transcription factor Forkhead Box O1 (FOXO1) is a critical regulator of endometrial receptivity in vivo. Uterine ablation of Foxo1 using the progesterone receptor Cre (PgrCre) mouse model resulted in infertility due to altered epithelial cell polarity and apoptosis, preventing the embryo from penetrating the luminal epithelium. Analysis of the uterine transcriptome after Foxo1 ablation identified alterations in gene expression for transcripts involved in the activation of cell invasion, molecular transport, apoptosis, β-catenin (CTNNB1) signaling pathway, and an increase in PGR signaling. The increase of PGR signaling was due to PGR expression being retained in the uterine epithelium during the window of receptivity. Constitutive expression of epithelial PGR during this receptive period inhibited expression of FOXO1 in the nucleus of the uterine epithelium. The reciprocal expression of PGR and FOXO1 was conserved in human endometrial samples during the proliferative and secretory phase. This demonstrates that expression of FOXO1 and the loss of PGR during the window of receptivity are interrelated and critical for embryo implantation., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
11. SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh.
- Author
-
Wang X, Li X, Wang T, Wu SP, Jeong JW, Kim TH, Young SL, Lessey BA, Lanz RB, Lydon JP, and DeMayo FJ
- Subjects
- Animals, CRISPR-Cas Systems genetics, CRISPR-Cas Systems physiology, Endometrium metabolism, Female, GATA2 Transcription Factor genetics, GATA2 Transcription Factor metabolism, HMGB Proteins genetics, Hedgehog Proteins genetics, Hedgehog Proteins metabolism, Hepatocyte Nuclear Factor 3-beta genetics, Hepatocyte Nuclear Factor 3-beta metabolism, Leukemia Inhibitory Factor genetics, Leukemia Inhibitory Factor metabolism, Mice, SOXF Transcription Factors genetics, Transcriptome genetics, HMGB Proteins metabolism, SOXF Transcription Factors metabolism, Uterus metabolism
- Abstract
Mammalian pregnancy depends on the ability of the uterus to support embryo implantation. Previous studies reveal the Sox17 gene as a downstream target of the Pgr-Gata2-dependent transcription network that directs genomic actions in the uterine endometrium receptive for embryo implantation. Here, we report that ablating Sox17 in the uterine epithelium impairs leukemia inhibitory factor (LIF) and Indian hedgehog homolog (IHH) signaling, leading to failure of embryo implantation. In vivo deletion of the SOX17-binding region 19 kb upstream of the Ihh locus by CRISPR-Cas technology reduces Ihh expression specifically in the uterus and alters proper endometrial epithelial-stromal interactions, thereby impairing pregnancy. This SOX17-binding interval is also bound by GATA2, FOXA2, and PGR. This cluster of transcription factor binding is common in 737 uterine genes and may represent a key regulatory element essential for uterine epithelial gene expression.
- Published
- 2018
- Full Text
- View/download PDF
12. Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics
- Author
-
Szwarc MM, Hai L, Gibbons WE, White LD, Mo Q, Kommagani R, Lanz RB, DeMayo FJ, O'Malley BW, and Lydon JP
- Subjects
- Cells, Cultured, Female, Humans, Receptors, Progesterone metabolism, Sequence Analysis, RNA, Endometrium physiology, Gene Expression Regulation, Membrane Proteins metabolism, Nuclear Receptor Coactivator 2 physiology, Transcriptome
- Abstract
Establishment of a successful pregnancy requires not only implantation of a healthy embryo into a receptive uterus but also progesterone receptor (PGR)-dependent transformation of endometrial stromal cells (ESCs) into specialized decidual cells. Decidual cells support the developing embryo and are critical for placentation. We have previously shown that a known transcriptional coregulator of the PGR, steroid receptor coactivator-2 (SRC-2), is a critical driver of endometrial decidualization in both human and mouse endometrium. However, the full spectrum of genes transcriptionally controlled by SRC-2 in decidualizing ESCs has not been identified. Therefore, using an RNA- and chromatin immunoprecipitation-sequencing approach, we have identified the transcriptome of decidualizing human ESCs (hESCs) that requires SRC-2. We revealed that the majority of hESC genes regulated by SRC-2 are associated with decidualization. Over 50% of SRC-2-regulated genes are also controlled by the PGR. While ontology analysis showed that SRC-2-dependent genes are functionally linked to signaling processes known to underpin hESC decidualization, cell membrane processes were significantly enriched in this analysis. Follow-up studies showed that retinoid signaling is dependent on SRC-2 during hESC decidualization. Specifically, SRC-2 is required for full induction of the retinol transporter, stimulated by retinoic acid 6 (STRA6), which is essential for hESC decidualization. Together our findings show that a critical subset of genes transcriptionally reprogramed by PGR during hESC decidualization requires SRC-2. Among the multiple genes, pathways and networks that are dependent on SRC-2 during hESC decidualization, first-line analysis supports a critical role for this coregulator in maintaining retinoid signaling during progesterone-driven decidualization., (© 2018 Society for Reproduction and Fertility)
- Published
- 2018
- Full Text
- View/download PDF
13. Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells.
- Author
-
Szwarc MM, Kommagani R, Putluri V, Dubrulle J, Stossi F, Mancini MA, Coarfa C, Lanz RB, Putluri N, DeMayo FJ, Lydon JP, and O'Malley BW
- Subjects
- Aldose-Ketose Isomerases antagonists & inhibitors, Aldose-Ketose Isomerases metabolism, Carbon Isotopes, Cell Line, Tumor, Cell Proliferation, Endometrium pathology, Female, Glycolysis genetics, Humans, Metabolome genetics, Nuclear Receptor Coactivator 2 antagonists & inhibitors, Nuclear Receptor Coactivator 2 metabolism, Oxidative Phosphorylation, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Aldose-Ketose Isomerases genetics, Endometrium metabolism, Gene Expression Regulation, Neoplastic, Nuclear Receptor Coactivator 2 genetics, Pentose Phosphate Pathway genetics
- Abstract
Steroid receptor coactivator-2 (SRC-2) is a transcriptional coregulator that modulates the activity of many transcription factors. Levels of SRC-2 are elevated in endometrial biopsies from polycystic ovary syndrome patients, a population predisposed to endometrial cancer (EC). Increased expression of SRC-2 is also detected in neoplastic endometrium suggesting a causal link between elevated SRC-2 expression and the emergence of endometrial disorders that can lead to cancer. Here, we reveal that SRC-2 knockdown reduces EC cell proliferation and anchorage-independence. Additionally, SRC-2 is required to maintain cellular glycolytic capacity and oxidative phosphorylation, processes essential for EC cell proliferation. Importantly, SRC-2 is critical for the normal performance of the pentose phosphate pathway (PPP). Perturbation of the PPP due to loss of SRC-2 expression may result from the depletion of ribose-5-P isomerase (RPIA), a key enzyme of the PPP. As with SRC-2, RPIA knockdown reduces EC cell proliferation, which is accompanied by a decrease in glycolytic capacity and oxidative phosphorylation. Glucose metabolite tracking experiments confirmed that knockdown of SRC-2 and RPIA downregulates the metabolic rate of both glycolysis and the PPP, highlighting a novel regulatory cross-talk between glycolysis and the PPP modulated by SRC-2.
- Published
- 2018
- Full Text
- View/download PDF
14. Maf1 and Repression of RNA Polymerase III-Mediated Transcription Drive Adipocyte Differentiation.
- Author
-
Chen CY, Lanz RB, Walkey CJ, Chang WH, Lu W, and Johnson DL
- Subjects
- Adipocytes cytology, Animals, Butyrate Response Factor 1, Cell Differentiation, Embryoid Bodies cytology, Embryoid Bodies metabolism, Fibroblasts cytology, Fibroblasts metabolism, Gene Expression Regulation, Developmental, Male, Mesoderm cytology, Mesoderm growth & development, Mesoderm metabolism, Mice, Mice, Nude, Mouse Embryonic Stem Cells cytology, Mouse Embryonic Stem Cells metabolism, Nuclear Proteins antagonists & inhibitors, Nuclear Proteins genetics, Nuclear Proteins metabolism, Primary Cell Culture, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, RNA Polymerase III metabolism, RNA, Long Noncoding genetics, RNA, Long Noncoding metabolism, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, RNA-Binding Proteins antagonists & inhibitors, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Repressor Proteins metabolism, Signal Transduction, Wnt Proteins genetics, Wnt Proteins metabolism, Adipocytes metabolism, Adipogenesis genetics, RNA Polymerase III genetics, Repressor Proteins genetics, Transcription, Genetic
- Abstract
RNA polymerase (pol) III transcribes a variety of small untranslated RNAs involved in transcription, RNA processing, and translation. RNA pol III and its components are altered in various human developmental disorders, yet their roles in cell fate determination and development are poorly understood. Here we demonstrate that Maf1, a transcriptional repressor, promotes induction of mouse embryonic stem cells (mESCs) into mesoderm. Reduced Maf1 expression in mESCs and preadipocytes impairs adipogenesis, while ectopic Maf1 expression in Maf1-deficient cells enhances differentiation. RNA pol III repression by chemical inhibition or knockdown of Brf1 promotes adipogenesis. Altered RNA pol III-dependent transcription produces select changes in mRNAs with a significant enrichment of adipogenic gene signatures. Furthermore, RNA pol III-mediated transcription positively regulates long non-coding RNA H19 and Wnt6 expression, established adipogenesis inhibitors. Together, these studies reveal an important and unexpected function for RNA pol III-mediated transcription and Maf1 in mesoderm induction and adipocyte differentiation., (Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
15. SRC-3 Coactivator Governs Dynamic Estrogen-Induced Chromatin Looping Interactions during Transcription.
- Author
-
Panigrahi AK, Foulds CE, Lanz RB, Hamilton RA, Yi P, Lonard DM, Tsai MJ, Tsai SY, and O'Malley BW
- Subjects
- Binding Sites, Breast Neoplasms metabolism, Breast Neoplasms pathology, Chromatin genetics, Enhancer Elements, Genetic, Estrogen Receptor alpha genetics, Estrogen Receptor alpha metabolism, Female, Humans, Nuclear Receptor Coactivator 3 genetics, Promoter Regions, Genetic, Protein Binding, Tumor Cells, Cultured, Breast Neoplasms genetics, Chromatin metabolism, Estrogens pharmacology, Gene Expression Regulation, Neoplastic, Nuclear Receptor Coactivator 3 metabolism, Transcription, Genetic
- Abstract
Enhancers are thought to activate transcription by physically contacting promoters via looping. However, direct assays demonstrating these contacts are required to mechanistically verify such cellular determinants of enhancer function. Here, we present versatile cell-free assays to further determine the role of enhancer-promoter contacts (EPCs). We demonstrate that EPC is linked to mutually stimulatory transcription at the enhancer and promoter in vitro. SRC-3 was identified as a critical looping determinant for the estradiol-(E2)-regulated GREB1 locus. Surprisingly, the GREB1 enhancer and promoter contact two internal gene body SRC-3 binding sites, GBS1 and GBS2, which stimulate their transcription. Utilizing time-course 3C assays, we uncovered SRC-3-dependent dynamic chromatin interactions involving the enhancer, promoter, GBS1, and GBS2. Collectively, these data suggest that the enhancer and promoter remain "poised" for transcription via their contacts with GBS1 and GBS2. Upon E2 induction, GBS1 and GBS2 disengage from the enhancer, allowing direct EPC for active transcription., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
16. Human endometrial stromal cell decidualization requires transcriptional reprogramming by PLZF.
- Author
-
Szwarc MM, Hai L, Gibbons WE, Peavey MC, White LD, Mo Q, Lonard DM, Kommagani R, Lanz RB, DeMayo FJ, and Lydon JP
- Subjects
- Cell Movement, Cell Proliferation, Cells, Cultured, Computational Biology, Female, Gene Expression Regulation physiology, Humans, Promyelocytic Leukemia Zinc Finger Protein genetics, RNA Interference, Stromal Cells cytology, Stromal Cells metabolism, Transcriptome, Decidua physiology, Endometrium cytology, Promyelocytic Leukemia Zinc Finger Protein metabolism
- Abstract
Infertility and early embryo miscarriage is linked to inadequate endometrial decidualization. Although transcriptional reprogramming is known to drive decidualization in response to progesterone, the key signaling effectors that directly mediate this hormone response are not fully known. This knowledge gap is clinically significant because identifying the early signals that directly mediate progesterone-driven decidualization will address some of the current limitations in diagnosing and therapeutically treating patients at most risk for early pregnancy loss. We recently revealed that the promyelocytic leukemia zinc finger (PLZF) is a direct target of the progesterone receptor and is essential for decidualization of human endometrial stromal cells (hESCs). The purpose of this current work was to identify the genome-wide transcriptional program that is controlled by PLZF during hESC decidualization using an established in vitro hESC culture model, siRNA-mediated knockdown methods, and RNA-sequencing technology followed by bioinformatic analysis and validation. We discovered that PLZF is critical in the regulation of genes that are involved in cellular processes that are essential for the archetypal morphological and functional changes that occur when hESCs transform into epithelioid decidual cells such as proliferation and cell motility. We predict that the transcriptome datasets identified in this study will not only contribute to a broader understanding of PLZF-dependent endometrial decidualization at the molecular level but may advance the development of more effective molecular diagnostics and therapeutics for the clinical management of female infertility and subfertility that is based on a dysfunctional endometrium., (© The Author(s) 2017. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2018
- Full Text
- View/download PDF
17. Temporal-Spatial Establishment of Initial Niche for the Primary Spermatogonial Stem Cell Formation Is Determined by an ARID4B Regulatory Network.
- Author
-
Wu RC, Zeng Y, Chen YF, Lanz RB, and Wu MY
- Subjects
- Animals, Animals, Newborn, Apoptosis, Cell Differentiation, Cell Lineage, Cell Self Renewal, DNA-Binding Proteins genetics, Down-Regulation genetics, Gene Expression Regulation, Developmental, Glial Cell Line-Derived Neurotrophic Factor metabolism, Male, Mice, Inbred C57BL, Mice, Knockout, Organ Specificity, Testis embryology, Testis metabolism, Time Factors, DNA-Binding Proteins metabolism, Gene Regulatory Networks, Spermatogonia cytology, Stem Cell Niche, Stem Cells cytology, Stem Cells metabolism
- Abstract
During neonatal testis development, centrally located gonocytes migrate to basement membrane of the seminiferous cords, where physical contact with a niche established by Sertoli cells is essential for transition of gonocytes into spermatogonial stem cells (SSCs). To provide structural support and signaling stimuli for the gonocyte-to-SSC transition that occurs at a specific location during a finite phase, temporal-spatial establishment of the niche is critical. To date, the factors that guide Sertoli cells to establish the initial stem cell niche remain largely unknown. Using the Sertoli cell-specific Arid4b knockout (Arid4bSCKO) mice, we demonstrated that ablation of AT-rich interaction domain 4B (ARID4B) resulted in abnormal detachment of Sertoli cells from the basement membrane of seminiferous cords during the gonocyte-to-SSC transition phase, suggesting failure to establish a niche for the SSC formation. Without support by a niche environment, gonocytes showed disarranged cell distribution in the Arid4bSCKO testes and underwent apoptosis. The commitment of gonocytes to differentiate into the spermatogonial lineage was broken and the capability of SSCs to self-renew and differentiate was also impaired. Gene expression profiling revealed the molecular mechanisms responsible for the phenotypic changes in the Arid4bSCKO testes, by identifying genes important for stem cell niche function as downstream effectors of ARID4B, including genes that encode gap junction protein alpha-1, KIT ligand, anti-Müllerian hormone, Glial cell-line derived neurotrophic factor, inhibin alpha, inhibin beta, and cytochrome P450 family 26 subfamily b polypeptide 1. Our results identified ARID4B as a master regulator of a signaling network that governs the establishment of a niche during the critical gonocyte-to-SSC transition phase to control the fate of gonocytes and SSCs. Stem Cells 2017;35:1554-1565., (© 2017 AlphaMed Press.)
- Published
- 2017
- Full Text
- View/download PDF
18. Decreased epithelial progesterone receptor A at the window of receptivity is required for preparation of the endometrium for embryo attachment.
- Author
-
Wetendorf M, Wu SP, Wang X, Creighton CJ, Wang T, Lanz RB, Blok L, Tsai SY, Tsai MJ, Lydon JP, and DeMayo FJ
- Subjects
- Alleles, Animals, Cloning, Molecular, Down-Regulation, Female, Gene Expression Regulation physiology, Hedgehog Proteins genetics, Hedgehog Proteins metabolism, Male, Mice, Transgenic, Receptors, OSM-LIF genetics, Receptors, OSM-LIF metabolism, Receptors, Progesterone genetics, Wnt Proteins genetics, Wnt Proteins metabolism, Embryo Implantation, Endometrium, Progesterone metabolism, Receptors, Progesterone metabolism
- Abstract
The precise timing of progesterone signaling through its cognate receptor, the progesterone receptor (PGR), is critical for the establishment and maintenance of pregnancy. Loss of PGR expression in the murine uterine epithelium during the preimplantation period is a marker for uterine receptivity and embryo attachment. We hypothesized that the decrease in progesterone receptor A (PGRA) expression is necessary for successful embryo implantation. To test this hypothesis, a mouse model constitutively expressing PGRA (mPgrALsL/+) was generated. Expression of PGRA in all uterine compartments (Pgrcre) or uterine epithelium (Wnt7acre) resulted in infertility with defects in embryo attachment and stromal decidualization. Expression of critical PGRA target genes, indian hedgehog, and amphiregulin (Areg), was maintained through the window of receptivity while the estrogen receptor target gene, the leukemia inhibitory factor (Lif), a key regulator of embryo receptivity, was decreased. Transcriptomic and cistromic analyses of the mouse uterus at day 4.5 of pregnancy identified an altered group of genes regulating molecular transport in the control of fluid and ion levels within the uterine interstitial space. Additionally, LIF and its cognate receptor, the leukemia inhibitory factor receptor (LIFR), exhibited PGR-binding events in regions upstream of the transcriptional start sites, suggesting PGRA is inhibiting transcription at these loci. Therefore, downregulation of the PGRA isoform at the window of receptivity is necessary for the attenuation of hedgehog signaling, transcriptional activation of LIF signaling, and modulation of solutes and fluid, producing a receptive environment for the attaching embryo.
- Published
- 2017
- Full Text
- View/download PDF
19. A Gata2-Dependent Transcription Network Regulates Uterine Progesterone Responsiveness and Endometrial Function.
- Author
-
Rubel CA, Wu SP, Lin L, Wang T, Lanz RB, Li X, Kommagani R, Franco HL, Camper SA, Tong Q, Jeong JW, Lydon JP, and DeMayo FJ
- Subjects
- Animals, Base Sequence, Conserved Sequence genetics, Embryo Implantation, Female, GATA2 Transcription Factor metabolism, Humans, Mice, Phosphoproteins metabolism, Pregnancy, Progesterone blood, Protein Binding genetics, Receptors, Progesterone metabolism, Signal Transduction genetics, Trans-Activators metabolism, Transcription Factors metabolism, Transcription, Genetic, Tumor Suppressor Proteins metabolism, Endometrium metabolism, Gene Regulatory Networks genetics, Progesterone metabolism
- Abstract
Altered progesterone responsiveness leads to female infertility and cancer, but underlying mechanisms remain unclear. Mice with uterine-specific ablation of GATA binding protein 2 (Gata2) are infertile, showing failures in embryo implantation, endometrial decidualization, and uninhibited estrogen signaling. Gata2 deficiency results in reduced progesterone receptor (PGR) expression and attenuated progesterone signaling, as evidenced by genome-wide expression profiling and chromatin immunoprecipitation. GATA2 not only occupies at and promotes expression of the Pgr gene but also regulates downstream progesterone responsive genes in conjunction with the PGR. Additionally, Gata2 knockout uteri exhibit abnormal luminal epithelia with ectopic TRP63 expressing squamous cells and a cancer-related molecular profile in a progesterone-independent manner. Lastly, we found a conserved GATA2-PGR regulatory network in both human and mice based on gene signature and path analyses using gene expression profiles of human endometrial tissues. In conclusion, uterine Gata2 regulates a key regulatory network of gene expression for progesterone signaling at the early pregnancy stage., (Published by Elsevier Inc.)
- Published
- 2016
- Full Text
- View/download PDF
20. The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.
- Author
-
Xiao L, Lanz RB, Frolov A, Castro PD, Zhang Z, Dong B, Xue W, Jung SY, Lydon JP, Edwards DP, Mancini MA, Feng Q, Ittmann MM, and He B
- Subjects
- Animals, Biomarkers, Tumor metabolism, Carrier Proteins biosynthesis, Cell Cycle Proteins, Cell Line, Tumor, Humans, Male, Mice, Mice, Inbred BALB C, Mice, Transgenic, Prostatic Neoplasms metabolism, Prostatic Neoplasms pathology, Transcriptional Regulator ERG biosynthesis, Transcriptional Regulator ERG genetics, Biomarkers, Tumor genetics, Carrier Proteins genetics, Gene Targeting methods, Germ Cells metabolism, Germ Cells pathology, Prostatic Neoplasms genetics
- Abstract
Background: TMPRSS2-ERG fusion occurs in about half of prostate cancers and results in over-expression of the oncogenic ERG protein in the prostate. The mechanism by which ERG contributes to prostate cancer initiation and progression remains largely unknown. Because ERG is a transcriptional activator, we reasoned that the target genes regulated by ERG could contribute to prostate cancer development., Methods: In a search for ERG target genes, we took advantage of published datasets from the MSKCC Prostate Oncogene Project, in which a comprehensive analysis was applied to define transcriptomes in 150 prostate tumors. We retrieved the mRNA expression dataset, split them based on ERG expression, and identified genes whose expression levels are associated with ERG mRNA levels., Results: mRNA expression levels of 21 genes were found to be significantly increased, while for one gene it was decreased in ERG-positive prostate tumors. Among them, the expression of TDRD1 was the most significantly increased in ERG-positive tumors. Among 131 primary prostate tumors which were primarily from European American patients, TDRD1 is over-expressed in 68% of samples, while ERG is overexpressed in 48% of samples, suggesting an additional ERG-independent mechanism of TDRD1 overexpression. In African American prostate tumors, TDRD1 mRNA is expressed in 44%, while ERG is expressed in 24% of samples. In normal tissues, TDRD1 mRNA is exclusively expressed in germ cells and its protein is also known as cancer/testis antigen 41.1 (CT41.1). We generated a mouse monoclonal antibody that recognizes human TDRD1 protein with high specificity and sensitivity. By Western blot analysis and immunohistochemistry (IHC) staining, we demonstrate that TDRD1 protein is expressed in the majority of human prostate tumors, but not in normal prostate tissue. Finally, TDRD1 is not induced in the prostate of ERG overexpression transgenic mice, suggesting that such model does not fully recapitulate the TMPRSS2/ERG fusion-dependent human prostate cancer development., Conclusions: Our results suggest TDRD1 as a novel prostate cancer biomarker. As an ERG target gene, TDRD1 might play an important role in human prostate cancer development, and as a cancer/testis antigen, TDRD1 might have long-term potential to be a therapeutic target for prostate cancer immunotherapy. Prostate 76:1271-1284, 2016. © 2016 Wiley Periodicals, Inc., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
21. The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.
- Author
-
Zhang Z, Lanz RB, Xiao L, Wang L, Hartig SM, Ittmann MM, Feng Q, and He B
- Subjects
- Animals, Cell Line, Tumor, Humans, Male, Mice, Mice, Transgenic, Prostatic Neoplasms pathology, Transcriptional Regulator ERG genetics, Transfection, MicroRNAs genetics, Prostatic Neoplasms genetics
- Abstract
The TMPRSS2-ERG fusion occurs in approximately 50% of prostate cancer (PCa), resulting in expression of the oncogenic ERG in the prostate. Because ERG is a transcriptional activator, we hypothesized that ERG-regulated genes contribute to PCa development. Since microRNA (miRNA) has crucial functions in cancer, we searched for miRNAs regulated by ERG in PCas. We mined published datasets based on the MSKCC Prostate Oncogene Project, in which a comprehensive analysis defined the miRNA transcriptomes in 113 PCas. We retrieved the miRNA expression datasets, and identified miRNAs differentially expressed between ERG-positive and ERG-negative samples. Out of 369 miRNAs, miR-200a, -200b, -429 and -205 are the only miRNAs significantly increased in ERG-positive tumors. Strikingly, miR-200a, -200b and -429 are transcribed as a single polycistronic transcript, suggesting they are regulated at the transcriptional level. With ChIP-qPCR and in vitro binding assay, we identified two functional ETS motifs in the miR-200b/a/429 gene promoter. Knockdown of ERG in PCa cells reduced expression of these three miRNAs. In agreement with the well-established tumor suppressor function, overexpression of the miR-200b/a/429 gene inhibited PCa cell growth and invasion. In summary, our study reveals that miR-200b/a/429 is an ERG target gene, which implicates an important role in TMPRSS2/ERG-dependent PCa development. Although induction of the tumor suppressive miR-200b subfamily by oncogenic ERG appears to be counterintuitive, it is consistent with the observation that the vast majority of primary prostate cancers are slow-growing and indolent., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2016
- Full Text
- View/download PDF
22. The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.
- Author
-
Kommagani R, Szwarc MM, Vasquez YM, Peavey MC, Mazur EC, Gibbons WE, Lanz RB, DeMayo FJ, and Lydon JP
- Subjects
- Decidua cytology, Decidua metabolism, Early Growth Response Protein 1 genetics, Endometrium metabolism, Female, Humans, Kruppel-Like Transcription Factors biosynthesis, Progestins pharmacology, Promyelocytic Leukemia Zinc Finger Protein, Receptors, Progesterone physiology, Stromal Cells metabolism, Transcription, Genetic physiology, Decidua physiology, Endometrium cytology, Kruppel-Like Transcription Factors physiology, Stromal Cells cytology
- Abstract
Progesterone, via the progesterone receptor (PGR), is essential for endometrial stromal cell decidualization, a cellular transformation event in which stromal fibroblasts differentiate into decidual cells. Uterine decidualization supports embryo implantation and placentation as well as subsequent events, which together ensure a successful pregnancy. Accordingly, impaired decidualization results not only in implantation failure or early fetal miscarriage, but also may lead to potential adverse outcomes in all three pregnancy trimesters. Transcriptional reprogramming on a genome-wide scale underlies progesterone dependent decidualization of the human endometrial stromal cell (hESC). However, identification of the functionally essential signals encoded by these global transcriptional changes remains incomplete. Importantly, this knowledge-gap undercuts future efforts to improve diagnosis and treatment of implantation failure based on a dysfunctional endometrium. By integrating genome-wide datasets derived from decidualization of hESCs in culture, we reveal that the promyelocytic leukemia zinc finger (PLZF) transcription factor is rapidly induced by progesterone and that this induction is indispensable for progesterone-dependent decidualization. Chromatin immunoprecipitation followed by next generation sequencing (ChIP-Seq) identified at least ten progesterone response elements within the PLZF gene, indicating that PLZF may act as a direct target of PGR signaling. The spatiotemporal expression profile for PLZF in both the human and mouse endometrium offers further support for stromal PLZF as a mediator of the progesterone decidual signal. To identify functional targets of PLZF, integration of PLZF ChIP-Seq and RNA Pol II RNA-Seq datasets revealed that the early growth response 1 (EGR1) transcription factor is a PLZF target for which its level of expression must be reduced to enable progesterone dependent hESC decidualization. Apart from furnishing essential insights into the molecular mechanisms by which progesterone drives hESC decidualization, our findings provide a new conceptual framework that could lead to new avenues for diagnosis and/or treatment of adverse reproductive outcomes associated with a dysfunctional uterus.
- Published
- 2016
- Full Text
- View/download PDF
23. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes.
- Author
-
Nikolai BC, Lanz RB, York B, Dasgupta S, Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM, Smith CL, and O'Malley BW
- Subjects
- Antineoplastic Agents pharmacology, Binding Sites drug effects, Binding Sites genetics, Breast Neoplasms drug therapy, Breast Neoplasms genetics, Cell Cycle drug effects, Cell Cycle genetics, Cell Line, Tumor, Cell Proliferation drug effects, Cyclin-Dependent Kinases genetics, DNA Replication drug effects, DNA Replication genetics, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Female, Humans, Phosphorylation drug effects, Signal Transduction drug effects, Signal Transduction genetics, Transcriptional Activation drug effects, Transcriptional Activation genetics, Cell Proliferation genetics, DNA genetics, E2F1 Transcription Factor genetics, Nuclear Receptor Coactivator 3 genetics, Phosphorylation genetics, Receptor, ErbB-2 genetics
- Abstract
Approximately 20% of early-stage breast cancers display amplification or overexpression of the ErbB2/HER2 oncogene, conferring poor prognosis and resistance to endocrine therapy. Targeting HER2(+) tumors with trastuzumab or the receptor tyrosine kinase (RTK) inhibitor lapatinib significantly improves survival, yet tumor resistance and progression of metastatic disease still develop over time. Although the mechanisms of cytosolic HER2 signaling are well studied, nuclear signaling components and gene regulatory networks that bestow therapeutic resistance and limitless proliferative potential are incompletely understood. Here, we use biochemical and bioinformatic approaches to identify effectors and targets of HER2 transcriptional signaling in human breast cancer. Phosphorylation and activity of the Steroid Receptor Coactivator-3 (SRC-3) is reduced upon HER2 inhibition, and recruitment of SRC-3 to regulatory elements of endogenous genes is impaired. Transcripts regulated by HER2 signaling are highly enriched with E2F1 binding sites and define a gene signature associated with proliferative breast tumor subtypes, cell-cycle progression, and DNA replication. We show that HER2 signaling promotes breast cancer cell proliferation through regulation of E2F1-driven DNA metabolism and replication genes together with phosphorylation and activity of the transcriptional coactivator SRC-3. Furthermore, our analyses identified a cyclin-dependent kinase (CDK) signaling node that, when targeted using the CDK4/6 inhibitor palbociclib, defines overlap and divergence of adjuvant pharmacologic targeting. Importantly, lapatinib and palbociclib strictly block de novo synthesis of DNA, mostly through disruption of E2F1 and its target genes. These results have implications for rational discovery of pharmacologic combinations in preclinical models of adjuvant treatment and therapeutic resistance., (©2016 American Association for Cancer Research.)
- Published
- 2016
- Full Text
- View/download PDF
24. Long Noncoding RNAs as Targets and Regulators of Nuclear Receptors.
- Author
-
Foulds CE, Panigrahi AK, Coarfa C, Lanz RB, and O'Malley BW
- Subjects
- Humans, Neoplasms genetics, Proteomics, Receptors, Cytoplasmic and Nuclear genetics, Signal Transduction physiology, RNA, Long Noncoding physiology, Receptors, Cytoplasmic and Nuclear physiology
- Abstract
Intensive research has been directed at the discovery, biogenesis, and expression patterns of long noncoding RNAs , yet their biochemical functions have remained elusive for the most part. Nuclear receptors that interpret signaling mediated by small molecule hormones play a role in regulating the expression of some long noncoding RNAs. More importantly, these RNAs have also been shown to effect hormone-affected gene transcription regulated by the nuclear receptors. In this chapter, we summarize the current knowledge that has been acquired on hormonal signaling inducing expression of long noncoding RNAs and how they then may act in trans or in cis to modulate gene transcription. We highlight a few of these noncoding RNA molecules in terms of how they may impact hormone-driven cancers. Future directions critical for moving this field forward are presented, with a clear emphasis on the need for better biochemical approaches to address the mechanism of action of these exciting RNAs.
- Published
- 2016
- Full Text
- View/download PDF
25. Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.
- Author
-
Mazur EC, Vasquez YM, Li X, Kommagani R, Jiang L, Chen R, Lanz RB, Kovanci E, Gibbons WE, and DeMayo FJ
- Subjects
- Adult, Cells, Cultured, Chromatin Immunoprecipitation, Female, Fos-Related Antigen-2 metabolism, Humans, Insulin-Like Growth Factor Binding Protein 1 metabolism, Receptors, Progesterone metabolism, Transcription Factor AP-1 metabolism, Transcriptome genetics, Endometrium cytology, Receptors, Progesterone genetics, Stromal Cells metabolism
- Abstract
Decidualization is a complex process involving cellular proliferation and differentiation of the endometrial stroma that is required to establish and support pregnancy. Progesterone acting via its nuclear receptor, the progesterone receptor (PGR), is a critical regulator of decidualization and is known to interact with certain members of the activator protein-1 (AP-1) family in the regulation of transcription. In this study, we identified the cistrome and transcriptome of PGR and identified the AP-1 factors FOSL2 and JUN to be regulated by PGR and important in the decidualization process. Direct targets of PGR were identified by integrating gene expression data from RNA sequencing with the whole-genome binding profile of PGR determined by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) in primary human endometrial stromal cells exposed to 17β-estradiol, medroxyprogesterone acetate, and cAMP to promote in vitro decidualization. Ablation of FOSL2 and JUN attenuates the induction of 2 decidual marker genes, IGFBP1 and PRL. ChIP-seq analysis of genomic binding revealed that FOSL2 is bound in proximity to 8586 distinct genes, including nearly 80% of genes bound by PGR. A comprehensive assessment of the PGR-dependent decidual transcriptome integrated with the genomic binding of PGR identified FOSL2 as a potentially important transcriptional coregulator of PGR via direct interaction with regulatory regions of genes actively regulated during decidualization.
- Published
- 2015
- Full Text
- View/download PDF
26. Structure of a biologically active estrogen receptor-coactivator complex on DNA.
- Author
-
Yi P, Wang Z, Feng Q, Pintilie GD, Foulds CE, Lanz RB, Ludtke SJ, Schmid MF, Chiu W, and O'Malley BW
- Subjects
- Binding Sites, Cryoelectron Microscopy, DNA chemistry, DNA metabolism, E1A-Associated p300 Protein metabolism, Estrogen Receptor alpha metabolism, Histone Acetyltransferases metabolism, Humans, Multiprotein Complexes chemistry, Multiprotein Complexes metabolism, Nuclear Receptor Coactivator 3 metabolism, Protein Conformation, Protein Structure, Tertiary, Response Elements, E1A-Associated p300 Protein chemistry, Estrogen Receptor alpha chemistry, Nuclear Receptor Coactivator 3 chemistry
- Abstract
Estrogen receptor (ER/ESR1) is a transcription factor critical for development, reproduction, metabolism, and cancer. ER function hinges on its ability to recruit primary and secondary coactivators, yet structural information on the full-length receptor-coactivator complex to complement preexisting and sometimes controversial biochemical information is lacking. Here, we use cryoelectron microscopy (cryo-EM) to determine the quaternary structure of an active complex of DNA-bound ERα, steroid receptor coactivator 3 (SRC-3/NCOA3), and a secondary coactivator (p300/EP300). Our structural model suggests the following assembly mechanism for the complex: each of the two ligand-bound ERα monomers independently recruits one SRC-3 protein via the transactivation domain of ERα; the two SRC-3s in turn bind to different regions of one p300 protein through multiple contacts. We also present structural evidence for the location of activation function 1 (AF-1) in a full-length nuclear receptor, which supports a role for AF-1 in SRC-3 recruitment., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
27. FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization.
- Author
-
Vasquez YM, Mazur EC, Li X, Kommagani R, Jiang L, Chen R, Lanz RB, Kovanci E, Gibbons WE, and DeMayo FJ
- Subjects
- Base Sequence, Binding Sites, Chromatin Immunoprecipitation, Female, Forkhead Box Protein O1, Forkhead Transcription Factors genetics, Gene Expression Regulation, Genome, Human, Humans, Molecular Sequence Data, Nucleotide Motifs genetics, Protein Binding, RNA, Small Interfering metabolism, Reproducibility of Results, Sequence Analysis, RNA, Software, Stromal Cells metabolism, Decidua cytology, Decidua metabolism, Forkhead Transcription Factors metabolism, Interferon Regulatory Factors metabolism, Receptors, Progesterone metabolism, Transcription, Genetic
- Abstract
The forkhead box O1A (FOXO1) is an early-induced target of the protein kinase A pathway during the decidualization of human endometrial stromal cells (HESCs). In this study we identified the cistrome and transcriptome of FOXO1 and its role as a transcriptional regulator of the progesterone receptor (PR). Direct targets of FOXO1 were identified by integrating RNA sequencing with chromatin immunoprecipitation followed by deep sequencing. Gene ontology analysis demonstrated that FOXO1 regulates a subset of genes in decidualization such as those involved in cancer, p53 signaling, focal adhesions, and Wnt signaling. An overlap of the FOXO1 and PR chromatin immunoprecipitation followed by deep sequencing intervals revealed the co-occupancy of FOXO1 in more than 75% of PR binding intervals. Among these intervals were highly enriched motifs for the interferon regulatory factor member 4 (IRF4). IRF4 was determined to be a genomic target of both FOXO1 and PR and also to be differentially regulated in HESCs treated with small interfering RNA targeting FOXO1 or PR prior to decidualization stimulus. Ablation of FOXO1 was found to abolish binding of PR to the shared binding interval downstream of the IRF4 gene. Finally, small interfering RNA-mediated ablation of IRF4 was shown to compromise morphological transformation of decidualized HESCs and to attenuate the expression of the decidual markers IGFBP1, PRL, and WNT4. These results provide the first evidence that FOXO1 is functionally required for the binding of PR to genomic targets. Most notably, FOXO1 and PR are required for the regulation of IRF4, a novel transcriptional regulator of decidualization in HESCs.
- Published
- 2015
- Full Text
- View/download PDF
28. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.
- Author
-
He B, Lanz RB, Fiskus W, Geng C, Yi P, Hartig SM, Rajapakshe K, Shou J, Wei L, Shah SS, Foley C, Chew SA, Eedunuri VK, Bedoya DJ, Feng Q, Minami T, Mitsiades CS, Frolov A, Weigel NL, Hilsenbeck SG, Rosen DG, Palzkill T, Ittmann MM, Song Y, Coarfa C, O'Malley BW, and Mitsiades N
- Subjects
- Cell Proliferation, Chromatin metabolism, Enhancer Elements, Genetic, Hepatocyte Nuclear Factor 3-alpha metabolism, Humans, Male, Prognosis, Receptors, Androgen physiology, Signal Transduction, Transcription, Genetic physiology, GATA2 Transcription Factor physiology, Nuclear Receptor Coactivators metabolism, Receptors, Androgen metabolism
- Abstract
The androgen receptor (AR) is a key driver of prostate cancer (PC), even in the state of castration-resistant PC (CRPC) and frequently even after treatment with second-line hormonal therapies such as abiraterone and enzalutamide. The persistence of AR activity via both ligand-dependent and ligand-independent mechanisms (including constitutively active AR splice variants) highlights the unmet need for alternative approaches to block AR signaling in CRPC. We investigated the transcription factor GATA-binding protein 2 (GATA2) as a regulator of AR signaling and an actionable therapeutic target in PC. We demonstrate that GATA2 directly promotes expression of both full-length and splice-variant AR, resulting in a strong positive correlation between GATA2 and AR expression in both PC cell lines and patient specimens. Conversely, GATA2 expression is repressed by androgen and AR, suggesting a negative feedback regulatory loop that, upon androgen deprivation, derepresses GATA2 to contribute to AR overexpression in CRPC. Simultaneously, GATA2 is necessary for optimal transcriptional activity of both full-length and splice-variant AR. GATA2 colocalizes with AR and Forkhead box protein A1 on chromatin to enhance recruitment of steroid receptor coactivators and formation of the transcriptional holocomplex. In agreement with these important functions, high GATA2 expression and transcriptional activity predicted worse clinical outcome in PC patients. A GATA2 small molecule inhibitor suppressed the expression and transcriptional function of both full-length and splice-variant AR and exerted potent anticancer activity against PC cell lines. We propose pharmacological inhibition of GATA2 as a first-in-field approach to target AR expression and function and improve outcomes in CRPC.
- Published
- 2014
- Full Text
- View/download PDF
29. Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
- Author
-
Qin J, Lee HJ, Wu SP, Lin SC, Lanz RB, Creighton CJ, DeMayo FJ, Tsai SY, and Tsai MJ
- Subjects
- Androgens physiology, Animals, Cell Line, Tumor, Disease Progression, Humans, Kaplan-Meier Estimate, MAP Kinase Signaling System, Male, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Hormone-Dependent metabolism, Neoplasms, Hormone-Dependent mortality, Neoplasms, Hormone-Dependent pathology, PTEN Phosphohydrolase metabolism, Proportional Hazards Models, Prostatic Intraepithelial Neoplasia mortality, Prostatic Intraepithelial Neoplasia secondary, Prostatic Neoplasms, Castration-Resistant mortality, Prostatic Neoplasms, Castration-Resistant pathology, Up-Regulation, Nuclear Receptor Coactivator 2 metabolism, Prostate metabolism, Prostatic Intraepithelial Neoplasia metabolism, Prostatic Neoplasms, Castration-Resistant metabolism
- Abstract
A major clinical hurdle for the management of advanced prostate cancer (PCa) in patients is the resistance of tumors to androgen deprivation therapy (ADT) and their subsequent development into castration-resistant prostate cancer (CRPC). While recent studies have identified potential pathways involved in CRPC development, the drivers of CRPC remain largely undefined. Here we determined that nuclear receptor coactivator 2 (NCoA2, also known as SRC-2), which is frequently amplified or overexpressed in patients with metastatic PCa, mediates development of CRPC. In a murine model, overexpression of NCoA2 in the prostate epithelium resulted in neoplasia and, in combination with Pten deletion, promoted the development of metastasis-prone cancer. Moreover, depletion of NCoA2 in PTEN-deficient mice prevented the development of CRPC. In human androgen-sensitive prostate cancer cells, androgen signaling suppressed NCoA2 expression, and NCoA2 overexpression in murine prostate tumors resulted in hyperactivation of PI3K/AKT and MAPK signaling, promoting tumor malignance. Analysis of PCa patient samples revealed a strong correlation among NCoA2-mediated signaling, disease progression, and PCa recurrence. Taken together, our findings indicate that androgen deprivation induces NCoA2, which in turn mediates activation of PI3K signaling and promotes PCa metastasis and CRPC development. Moreover, these results suggest that the inhibition of NCoA2 has potential for PCa therapy.
- Published
- 2014
- Full Text
- View/download PDF
30. The epidermal growth factor receptor critically regulates endometrial function during early pregnancy.
- Author
-
Large MJ, Wetendorf M, Lanz RB, Hartig SM, Creighton CJ, Mancini MA, Kovanci E, Lee KF, Threadgill DW, Lydon JP, Jeong JW, and DeMayo FJ
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Animals, Bone Morphogenetic Protein 2 genetics, Cell Differentiation genetics, Decidua metabolism, Endometriosis genetics, Female, Humans, Intracellular Signaling Peptides and Proteins genetics, Mice, Mice, Knockout, Minor Histocompatibility Antigens, Pregnancy, Protein Serine-Threonine Kinases genetics, RNA Interference, RNA, Small Interfering, Receptor, ErbB-2 genetics, Receptor, ErbB-3 genetics, Signal Transduction genetics, WNK Lysine-Deficient Protein Kinase 1, Wnt4 Protein genetics, Abortion, Spontaneous genetics, ErbB Receptors genetics, Fertility genetics, Pregnancy Complications genetics
- Abstract
Infertility and adverse gynecological outcomes such as preeclampsia and miscarriage represent significant female reproductive health concerns. The spatiotemporal expression of growth factors indicates that they play an important role in pregnancy. The goal of this study is to define the role of the ERBB family of growth factor receptors in endometrial function. Using conditional ablation in mice and siRNA in primary human endometrial stromal cells, we identified the epidermal growth factor receptor (Egfr) to be critical for endometrial function during early pregnancy. While ablation of Her2 or Erbb3 led to only a modest reduction in litter size, mice lacking Egfr expression are severely subfertile. Pregnancy demise occurred shortly after blastocyst implantation due to defects in decidualization including decreased proliferation, cell survival, differentiation and target gene expression. To place Egfr in a genetic regulatory hierarchy, transcriptome analyses was used to compare the gene signatures from mice with conditional ablation of Egfr, wingless-related MMTV integration site 4 (Wnt4) or boneless morphogenic protein 2 (Bmp2); revealing that not only are Bmp2 and Wnt4 key downstream effectors of Egfr, but they also regulate distinct physiological functions. In primary human endometrial stromal cells, marker gene expression, a novel high content image-based approach and phosphokinase array analysis were used to demonstrate that EGFR is a critical regulator of human decidualization. Furthermore, inhibition of EGFR signaling intermediaries WNK1 and AKT1S1, members identified in the kinase array and previously unreported to play a role in the endometrium, also attenuate decidualization. These results demonstrate that EGFR plays an integral role in establishing the cellular context necessary for successful pregnancy via the activation of intricate signaling and transcriptional networks, thereby providing valuable insight into potential therapeutic targets.
- Published
- 2014
- Full Text
- View/download PDF
31. Novel DNA motif binding activity observed in vivo with an estrogen receptor α mutant mouse.
- Author
-
Hewitt SC, Li L, Grimm SA, Winuthayanon W, Hamilton KJ, Pockette B, Rubel CA, Pedersen LC, Fargo D, Lanz RB, DeMayo FJ, Schütz G, and Korach KS
- Subjects
- Animals, Base Sequence, Consensus Sequence, Estradiol physiology, Estrogen Receptor alpha metabolism, Female, Kruppel-Like Factor 4, Kruppel-Like Transcription Factors genetics, Kruppel-Like Transcription Factors metabolism, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Knockout, Mutation, Missense, Nuclear Proteins genetics, Nuclear Proteins metabolism, Phenotype, Protein Binding, Response Elements, Uterus metabolism, Estrogen Receptor alpha genetics, Transcriptional Activation
- Abstract
Estrogen receptor α (ERα) interacts with DNA directly or indirectly via other transcription factors, referred to as "tethering." Evidence for tethering is based on in vitro studies and a widely used "KIKO" mouse model containing mutations that prevent direct estrogen response element DNA- binding. KIKO mice are infertile, due in part to the inability of estradiol (E2) to induce uterine epithelial proliferation. To elucidate the molecular events that prevent KIKO uterine growth, regulation of the pro-proliferative E2 target gene Klf4 and of Klf15, a progesterone (P4) target gene that opposes the pro-proliferative activity of KLF4, was evaluated. Klf4 induction was impaired in KIKO uteri; however, Klf15 was induced by E2 rather than by P4. Whole uterine chromatin immunoprecipitation-sequencing revealed enrichment of KIKO ERα binding to hormone response elements (HREs) motifs. KIKO binding to HRE motifs was verified using reporter gene and DNA-binding assays. Because the KIKO ERα has HRE DNA-binding activity, we evaluated the "EAAE" ERα, which has more severe DNA-binding domain mutations, and demonstrated a lack of estrogen response element or HRE reporter gene induction or DNA-binding. The EAAE mouse has an ERα null-like phenotype, with impaired uterine growth and transcriptional activity. Our findings demonstrate that the KIKO mouse model, which has been used by numerous investigators, cannot be used to establish biological functions for ERα tethering, because KIKO ERα effectively stimulates transcription using HRE motifs. The EAAE-ERα DNA-binding domain mutant mouse demonstrates that ERα DNA-binding is crucial for biological and transcriptional processes in reproductive tissues and that ERα tethering may not contribute to estrogen responsiveness in vivo.
- Published
- 2014
- Full Text
- View/download PDF
32. SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm.
- Author
-
Stashi E, Lanz RB, Mao J, Michailidis G, Zhu B, Kettner NM, Putluri N, Reineke EL, Reineke LC, Dasgupta S, Dean A, Stevenson CR, Sivasubramanian N, Sreekumar A, Demayo F, York B, Fu L, and O'Malley BW
- Subjects
- ARNTL Transcription Factors genetics, ARNTL Transcription Factors metabolism, Animals, CLOCK Proteins genetics, CLOCK Proteins metabolism, Liver metabolism, Male, Mice, Nuclear Receptor Coactivator 2 genetics, Organ Specificity, Transcriptome, Circadian Rhythm, Metabolome, Nuclear Receptor Coactivator 2 metabolism
- Abstract
Synchrony of the mammalian circadian clock is achieved by complex transcriptional and translational feedback loops centered on the BMAL1:CLOCK heterodimer. Modulation of circadian feedback loops is essential for maintaining rhythmicity, yet the role of transcriptional coactivators in driving BMAL1:CLOCK transcriptional networks is largely unexplored. Here, we show diurnal hepatic steroid receptor coactivator 2 (SRC-2) recruitment to the genome that extensively overlaps with the BMAL1 cistrome during the light phase, targeting genes that enrich for circadian and metabolic processes. Notably, SRC-2 ablation impairs wheel-running behavior, alters circadian gene expression in several peripheral tissues, alters the rhythmicity of the hepatic metabolome, and deregulates the synchronization of cell-autonomous metabolites. We identify SRC-2 as a potent coregulator of BMAL1:CLOCK and find that SRC-2 targets itself with BMAL1:CLOCK in a feedforward loop. Collectively, our data suggest that SRC-2 is a transcriptional coactivator of the BMAL1:CLOCK oscillators and establish SRC-2 as a critical positive regulator of the mammalian circadian clock., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
33. COUP-TFII regulates human endometrial stromal genes involved in inflammation.
- Author
-
Li X, Large MJ, Creighton CJ, Lanz RB, Jeong JW, Young SL, Lessey BA, Palomino WA, Tsai SY, and Demayo FJ
- Subjects
- Adolescent, Adult, Animals, Binding Sites, Choristoma genetics, Choristoma pathology, Chromatin Immunoprecipitation, Decidua metabolism, Female, Genome, Human genetics, Humans, Mice, Middle Aged, Oligonucleotide Array Sequence Analysis, Protein Binding, RNA, Small Interfering metabolism, Reproducibility of Results, Signal Transduction genetics, Stromal Cells metabolism, Stromal Cells pathology, Young Adult, COUP Transcription Factor II metabolism, Endometrium metabolism, Endometrium pathology, Gene Expression Regulation, Inflammation genetics, Inflammation pathology
- Abstract
Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII; NR2F2) is an orphan nuclear receptor involved in cell-fate specification, organogenesis, angiogenesis, and metabolism. Ablation of COUP-TFII in the mouse uterus causes infertility due to defects in embryo attachment and impaired uterine stromal cell decidualization. Although the function of COUP-TFII in uterine decidualization has been described in mice, its role in the human uterus remains unknown. We observed that, as in mice, COUP-TFII is robustly expressed in the endometrial stroma of healthy women, and its expression is reduced in the ectopic lesions of women with endometriosis. To interrogate the role of COUP-TFII in human endometrial function, we used a small interfering RNA-mediated loss of function approach in primary human endometrial stromal cells. Attenuation of COUP-TFII expression did not completely block decidualization; rather it had a selective effect on gene expression. To better elucidate the role of COUP-TFII in endometrial stroma cell biology, the COUP-TFII transcriptome was defined by pairing microarray comparison with chromatin immunoprecipitation followed by deep sequencing. Gene ontology analysis demonstrates that COUP-TFII regulates a subset of genes in endometrial stroma cell decidualization such as those involved in cell adhesion, angiogenesis, and inflammation. Importantly this analysis shows that COUP-TFII plays a role in controlling the expression of inflammatory cytokines. The determination that COUP-TFII plays a role in inflammation may add insight into the role of COUP-TFII in embryo implantation and in endometrial diseases such as endometriosis.
- Published
- 2013
- Full Text
- View/download PDF
34. Atrial identity is determined by a COUP-TFII regulatory network.
- Author
-
Wu SP, Cheng CM, Lanz RB, Wang T, Respress JL, Ather S, Chen W, Tsai SJ, Wehrens XH, Tsai MJ, and Tsai SY
- Subjects
- Action Potentials, Animals, Basic Helix-Loop-Helix Transcription Factors genetics, Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Differentiation, Cell Proliferation, Cell Size, Chromatin Immunoprecipitation, Embryo, Mammalian cytology, Embryo, Mammalian metabolism, Heart Atria embryology, Heart Atria growth & development, Heart Ventricles cytology, Heart Ventricles embryology, Heart Ventricles metabolism, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocardium metabolism, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Protein Binding, RNA, Messenger genetics, RNA, Messenger metabolism, Repressor Proteins genetics, T-Box Domain Proteins genetics, T-Box Domain Proteins metabolism, Tumor Suppressor Proteins genetics, Gene Expression Regulation, Developmental, Heart Atria metabolism, Repressor Proteins metabolism, Tumor Suppressor Proteins metabolism
- Abstract
Atria and ventricles exhibit distinct molecular profiles that produce structural and functional differences between the two cardiac compartments. However, the factors that determine these differences remain largely undefined. Cardiomyocyte-specific COUP-TFII ablation produces ventricularized atria that exhibit ventricle-like action potentials, increased cardiomyocyte size, and development of extensive T tubules. Changes in atrial characteristics are accompanied by alterations of 2,584 genes, of which 81% were differentially expressed between atria and ventricles, suggesting that a major function of myocardial COUP-TFII is to determine atrial identity. Chromatin immunoprecipitation assays using E13.5 atria identified classic atrial-ventricular identity genes Tbx5, Hey2, Irx4, MLC2v, MLC2a, and MLC1a, among many other cardiac genes, as potential COUP-TFII direct targets. Collectively, our results reveal that COUP-TFII confers atrial identity through direct binding and by modulating expression of a broad spectrum of genes that have an impact on atrial development and function., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
35. RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators.
- Author
-
Redfern AD, Colley SM, Beveridge DJ, Ikeda N, Epis MR, Li X, Foulds CE, Stuart LM, Barker A, Russell VJ, Ramsay K, Kobelke SJ, Li X, Hatchell EC, Payne C, Giles KM, Messineo A, Gatignol A, Lanz RB, O'Malley BW, and Leedman PJ
- Subjects
- Blotting, Western, Cell Fractionation, Chromatin Immunoprecipitation, Cloning, Molecular, HEK293 Cells, HeLa Cells, Humans, Luciferases, MCF-7 Cells, Plasmids genetics, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Transfection, Two-Hybrid System Techniques, Carrier Proteins metabolism, DEAD-box RNA Helicases metabolism, Gene Expression Regulation genetics, MicroRNAs metabolism, RNA-Binding Proteins metabolism, RNA-Induced Silencing Complex metabolism, Ribonuclease III metabolism
- Abstract
The cytoplasmic RNA-induced silencing complex (RISC) contains dsRNA binding proteins, including protein kinase RNA activator (PACT), transactivation response RNA binding protein (TRBP), and Dicer, that process pre-microRNAs into mature microRNAs (miRNAs) that target specific mRNA species for regulation. There is increasing evidence for important functional interactions between the miRNA and nuclear receptor (NR) signaling networks, with recent data showing that estrogen, acting through the estrogen receptor, can modulate initial aspects of nuclear miRNA processing. Here, we show that the cytoplasmic RISC proteins PACT, TRBP, and Dicer are steroid receptor RNA activator (SRA) binding NR coregulators that target steroid-responsive promoters and regulate NR activity and downstream gene expression. Furthermore, each of the RISC proteins, together with Argonaute 2, associates with SRA and specific pre-microRNAs in both the nucleus and cytoplasm, providing evidence for links between NR-mediated transcription and some of the factors involved in miRNA processing.
- Published
- 2013
- Full Text
- View/download PDF
36. Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.
- Author
-
Hartig SM, He B, Newberg JY, Ochsner SA, Loose DS, Lanz RB, McKenna NJ, Buehrer BM, McGuire SE, Marcelli M, and Mancini MA
- Subjects
- 3T3-L1 Cells, Adipocytes cytology, Androgen Receptor Antagonists metabolism, Animals, Cell Differentiation drug effects, Cells, Cultured, Dihydrotestosterone pharmacology, Glucocorticoids metabolism, Humans, Mice, Receptors, Glucocorticoid metabolism, Structure-Activity Relationship, Support Vector Machine, Transcription, Genetic drug effects, Adipocytes drug effects, Adipocytes metabolism, Androgen Receptor Antagonists pharmacology, Glucocorticoids pharmacology, Receptors, Androgen metabolism
- Abstract
We compared transcriptomes of terminally differentiated mouse 3T3-L1 and human adipocytes to identify cell-specific differences. Gene expression and high content analysis (HCA) data identified the androgen receptor (AR) as both expressed and functional, exclusively during early human adipocyte differentiation. The AR agonist dihydrotestosterone (DHT) inhibited human adipocyte maturation by downregulation of adipocyte marker genes, but not in 3T3-L1. It is interesting that AR induction corresponded with dexamethasone activation of the glucocorticoid receptor (GR); however, when exposed to the differentiation cocktail required for adipocyte maturation, AR adopted an antagonist conformation and was transcriptionally repressed. To further explore effectors within the cocktail, we applied an image-based support vector machine (SVM) classification scheme to show that adipocyte differentiation components inhibit AR action. The results demonstrate human adipocyte differentiation, via GR activation, upregulates AR but also inhibits AR transcriptional activity., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
37. Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus.
- Author
-
Rubel CA, Lanz RB, Kommagani R, Franco HL, Lydon JP, and DeMayo FJ
- Subjects
- Animals, Base Sequence, Binding Sites, Cells, Cultured, Chromatin metabolism, Chromatin Immunoprecipitation, Consensus Sequence, Female, Genome, Humans, Mice, Mice, Inbred C57BL, Molecular Sequence Annotation, Progesterone physiology, Protein Binding, Real-Time Polymerase Chain Reaction, Response Elements, Sequence Analysis, DNA, Signal Transduction, Transcriptome, HMGB Proteins metabolism, Receptors, Progesterone metabolism, SOXF Transcription Factors metabolism, Uterus metabolism
- Abstract
Progesterone (P4) signaling through its nuclear transcription factor, the progesterone receptor (PR), is essential for normal uterine function. Although deregulation of PR-mediated signaling is known to underscore uterine dysfunction and a number of endometrial pathologies, the early molecular mechanisms of this deregulation are unclear. To address this issue, we have defined the genome-wide PR cistrome in the murine uterus using chromatin immunoprecipitation (ChIP) followed by massively parallel sequencing (ChIP-seq). In uteri of ovariectomized mice, we identified 6367 PR-binding sites in the absence of P4 ligand; however, this number increased at nearly 3-fold (18,432) after acute P4 exposure. Sequence analysis revealed that approximately 73% of these binding sites contain a progesterone response element or a half-site motif recognized by the PR. Many previously identified P4 target genes known to regulate uterine function were found to contain PR-binding sites, confirming the validity of our methodology. Interestingly, when the ChIP-seq data were coupled with our microarray expression data, we identified a novel regulatory role for uterine P4 in circadian rhythm gene expression, thereby uncovering a hitherto unexpected new circadian biology for P4 in this tissue. Further mining of the ChIP-seq data revealed Sox17 as a direct transcriptional PR target gene in the uterus. As a member of the Sox transcription factor family, Sox17 represents a potentially novel mediator of PR action in the murine uterus. Collectively, our first line of analysis of the uterine PR cistrome provides the first insights into the early molecular mechanisms that underpin normal uterine responsiveness to acute P4 exposure. Future analysis promises to reveal the PR interactome and, in turn, potential therapeutic targets for the diagnosis and/or treatment of endometrial dysfunction.
- Published
- 2012
- Full Text
- View/download PDF
38. Recovering protein-protein and domain-domain interactions from aggregation of IP-MS proteomics of coregulator complexes.
- Author
-
Mazloom AR, Dannenfelser R, Clark NR, Grigoryan AV, Linder KM, Cardozo TJ, Bond JC, Boran AD, Iyengar R, Malovannaya A, Lanz RB, and Ma'ayan A
- Subjects
- Algorithms, Animals, Computer Simulation, Humans, Intracellular Signaling Peptides and Proteins chemistry, Models, Statistical, Molecular Conformation, Protein Binding, Protein Kinases chemistry, Protein Phosphatase 2 chemistry, Protein Serine-Threonine Kinases chemistry, Protein Structure, Tertiary, Software, Immunoprecipitation methods, Mass Spectrometry methods, Protein Interaction Mapping, Proteomics methods
- Abstract
Coregulator proteins (CoRegs) are part of multi-protein complexes that transiently assemble with transcription factors and chromatin modifiers to regulate gene expression. In this study we analyzed data from 3,290 immuno-precipitations (IP) followed by mass spectrometry (MS) applied to human cell lines aimed at identifying CoRegs complexes. Using the semi-quantitative spectral counts, we scored binary protein-protein and domain-domain associations with several equations. Unlike previous applications, our methods scored prey-prey protein-protein interactions regardless of the baits used. We also predicted domain-domain interactions underlying predicted protein-protein interactions. The quality of predicted protein-protein and domain-domain interactions was evaluated using known binary interactions from the literature, whereas one protein-protein interaction, between STRN and CTTNBP2NL, was validated experimentally; and one domain-domain interaction, between the HEAT domain of PPP2R1A and the Pkinase domain of STK25, was validated using molecular docking simulations. The scoring schemes presented here recovered known, and predicted many new, complexes, protein-protein, and domain-domain interactions. The networks that resulted from the predictions are provided as a web-based interactive application at http://maayanlab.net/HT-IP-MS-2-PPI-DDI/.
- Published
- 2011
- Full Text
- View/download PDF
39. Analysis of the human endogenous coregulator complexome.
- Author
-
Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G, Kim BJ, Li C, Chen R, Li W, Wang Y, O'Malley BW, and Qin J
- Subjects
- Amino Acid Sequence, BRCA1 Protein metabolism, Genome-Wide Association Study, Humans, Immunoprecipitation, Mass Spectrometry, Molecular Sequence Data, Protein Interaction Mapping, Receptors, Cytoplasmic and Nuclear metabolism, Transcription, Genetic, Proteins metabolism, Proteome analysis
- Abstract
Elucidation of endogenous cellular protein-protein interactions and their networks is most desirable for biological studies. Here we report our study of endogenous human coregulator protein complex networks obtained from integrative mass spectrometry-based analysis of 3290 affinity purifications. By preserving weak protein interactions during complex isolation and utilizing high levels of reciprocity in the large dataset, we identified many unreported protein associations, such as a transcriptional network formed by ZMYND8, ZNF687, and ZNF592. Furthermore, our work revealed a tiered interplay within networks that share common proteins, providing a conceptual organization of a cellular proteome composed of minimal endogenous modules (MEMOs), complex isoforms (uniCOREs), and regulatory complex-complex interaction networks (CCIs). This resource will effectively fill a void in linking correlative genomic studies with an understanding of transcriptional regulatory protein functions within the proteome for formulation and testing of future hypotheses., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
40. Estrogen-regulated prohibitin is required for mouse uterine development and adult function.
- Author
-
He B, Kim TH, Kommagani R, Feng Q, Lanz RB, Jeong JW, DeMayo FJ, Katzenellenbogen BS, Lydon JP, and O'Malley BW
- Subjects
- Alleles, Animals, Breast Neoplasms, Cell Line, Tumor, Estrogens genetics, Female, Gene Deletion, Gene Expression Regulation, Neoplastic, Genotype, Humans, Mice, Mutation, Prohibitins, Pseudopregnancy, RNA, Messenger genetics, RNA, Messenger metabolism, Repressor Proteins genetics, Signal Transduction, Time Factors, Uterus metabolism, Estrogens metabolism, Gene Expression Regulation, Developmental physiology, Repressor Proteins metabolism, Uterus growth & development
- Abstract
Estrogen signaling is pivotal for maintenance of female reproductive function in mammals. The physiological role of estrogen is mediated by estrogen receptors (ERs) and the steroid receptor coactivator family of transcriptional coregulators. Ablation of steroid receptor coactivator and ER coactivators in mice causes impaired female reproductive function. Recently we reported that prohibitin (PHB) can function as a corepressor for ERs in cultured cells. In this study, we demonstrate that PHB is an estrogen-regulated gene in vitro and in vivo, and its expression is induced by estrogen in the uterus, suggesting the existence of feedback regulatory loops. A conditional PHB knockout mouse model was generated by gene targeting to assess its in vivo function. Female mice with selective ablation of the PHB allele in the uterus were sterile, and their uteri were severely hypoplastic, indicating PHB is required for uterine development. Moreover, expression of ER and progesterone receptor target genes was selectively altered in response to hormone treatment. In summary, this study demonstrates that PHB is an estrogen-regulated gene and that PHB is essential for mouse uterine development and adult function and selectively required for estrogen-regulated gene expression.
- Published
- 2011
- Full Text
- View/download PDF
41. Global characterization of transcriptional impact of the SRC-3 coregulator.
- Author
-
Lanz RB, Bulynko Y, Malovannaya A, Labhart P, Wang L, Li W, Qin J, Harper M, and O'Malley BW
- Subjects
- Binding Sites genetics, Blotting, Western, Cell Line, Chromatin metabolism, Chromatin Immunoprecipitation, Estradiol pharmacology, Estrogen Receptor alpha metabolism, Genome, Human genetics, Hepatocyte Nuclear Factor 3-alpha metabolism, Humans, Polymerase Chain Reaction, RNA Interference, RNA Polymerase II metabolism, Signal Transduction drug effects, Breast Neoplasms metabolism, Nuclear Receptor Coactivator 3 metabolism
- Abstract
The nuclear receptor and bona fide oncogene, steroid receptor coactivator-3 (SRC-3, AIB1), acts as a master transcriptional regulator of breast cancer by transducing growth signals via the estrogen receptor alpha (ER). In this resource paper, we present the genome-wide localization analysis of SRC-3 chromatin affinity sites in MCF-7 human breast cancer chromatin and compare the cis binding sites to global cartographies for ER and FoxA1. By correlating their gene proximal binding sites to integrated gene expression signatures, and in combination with gene ontology analyses, we provide a functional classification of estradiol-induced gene regulation that further highlights an intricate transcriptional control of interdependent cellular pathways by SRC-3. Furthermore, by presenting proteomics analyses of in vivo SRC-3- and ER-associated proteins, we give strong evidence to support the idea that the interpretative power of SRC-3 in estrogen signaling is mediated through the formation of distinct, cell state-dependent protein complexes. Altogether, we present the first approach in complementary comparative analyses that converges results obtained by three discovery-driven methods (cistromics, transcriptomics, and proteomics) into testable hypotheses, thus providing a valuable resource for follow-up studies that further our understanding of estrogen signaling in human diseases in general and breast cancer in particular.
- Published
- 2010
- Full Text
- View/download PDF
42. Streamlined analysis schema for high-throughput identification of endogenous protein complexes.
- Author
-
Malovannaya A, Li Y, Bulynko Y, Jung SY, Wang Y, Lanz RB, O'Malley BW, and Qin J
- Subjects
- HeLa Cells, Histone Deacetylase 1 metabolism, Histone Deacetylase 2 metabolism, Humans, Models, Biological, Protein Binding, Proteins metabolism, Immunoprecipitation methods, Mass Spectrometry methods, Multiprotein Complexes metabolism, Protein Interaction Mapping methods
- Abstract
Immunoprecipitation followed by mass spectrometry (IP/MS) has recently emerged as a preferred method in the analysis of protein complex components and cellular protein networks. Targeting endogenous protein complexes of higher eukaryotes, particularly in large-scale efforts, has been challenging due to cellular heterogeneity, high proteome complexity, and, compared to lower organisms, lack of efficient in-locus epitope-tagging techniques. It is further complicated by variability in nonspecific identifications and cross-reactivity of primary antibodies. Still, the study of endogenous human protein networks is highly desired despite its challenges. Here we describe a streamlined IP/MS protocol for the purification and identification of extended endogenous protein complexes. We investigate the sources of nonspecific protein binding and develop semiquantitative specificity filters that are based on peptide spectral count measurements. We also outline logical constraints for the derivation of accurate complex composition from IP/MS data and demonstrate the effectiveness of this approach by presenting our analyses of different transcriptional coregulator complexes. We show consistent purification of novel components for the Integrator complex, analyze the composition of the Mediator complex solely from our data to demonstrate the wide usability of spectral counts, and deconvolute heterogeneous HDAC1/2 networks into core complex modules and several novel subcomplex interactions.
- Published
- 2010
- Full Text
- View/download PDF
43. Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.
- Author
-
McKenna NJ, Cooney AJ, DeMayo FJ, Downes M, Glass CK, Lanz RB, Lazar MA, Mangelsdorf DJ, Moore DD, Qin J, Steffen DL, Tsai MJ, Tsai SY, Yu R, Margolis RN, Evans RM, and O'Malley BW
- Subjects
- Gene Expression Profiling, International Cooperation, Internet, Computational Biology, Receptors, Cytoplasmic and Nuclear metabolism, Signal Transduction
- Abstract
Nuclear receptors and coregulators are multifaceted players in normal metabolic and homeostatic processes in addition to a variety of disease states including cancer, inflammation, diabetes, obesity, and atherosclerosis. Over the past 7 yr, the Nuclear Receptor Signaling Atlas (NURSA) research consortium has worked toward establishing a discovery-driven platform designed to address key questions concerning the expression, organization, and function of these molecules in a variety of experimental model systems. By applying powerful technologies such as quantitative PCR, high-throughput mass spectrometry, and embryonic stem cell manipulation, we are pursuing these questions in a series of transcriptomics-, proteomics-, and metabolomics-based research projects and resources. The consortium's web site (www.nursa.org) integrates NURSA datasets and existing public datasets with the ultimate goal of furnishing the bench scientist with a comprehensive framework for hypothesis generation, modeling, and testing. We place a strong emphasis on community input into the development of this resource and to this end have published datasets from academic and industrial laboratories, established strategic alliances with Endocrine Society journals, and are developing tools to allow web site users to act as data curators. With the ongoing support of the nuclear receptor and coregulator signaling communities, we believe that NURSA can make a lasting contribution to research in this dynamic field.
- Published
- 2009
- Full Text
- View/download PDF
44. Cracking the coregulator codes.
- Author
-
O'Malley BW, Qin J, and Lanz RB
- Subjects
- Animals, Histone Acetyltransferases genetics, Humans, Nuclear Receptor Coactivator 3, Repressor Proteins genetics, Transcription Factors genetics, Gene Expression Regulation genetics, Protein Processing, Post-Translational genetics, Proteome genetics, Receptors, Cytoplasmic and Nuclear genetics, Trans-Activators genetics, Transcription, Genetic genetics
- Abstract
The study of the genetic code has collectively revealed that the biochemical basis of heredity is uniform for nearly all known forms of life. Genetic approaches have generated a much better appreciation and understanding of many aspects of biological processes-and in some cases provided strategies for the treatment of human diseases. Still, the enormous and undoubtedly impressive amount of information gathered on gene sequences, their myriad expression patterns and translation into proteins is insufficient to answer seemingly simpler questions such as to what sets us humans apart from much more undemanding species while sharing almost the same sets of genes. Regulation of the proteome by post-translational modifications (PTMs) is beginning to be understood as a major contributing factor to the structural and functional diversity in biology and for defining cellular mechanisms in particular. Covalent, PTMs provide an astonishingly rich and specific basis for an ultrafast regulation of cellular processes, many of which converge to transcription units to control gene expression. With this essay we intend to share with the reader the rapid growth of our knowledge of the many conjunctions that exist between PTMs and key cellular processes that have emerged by studying the nuclear receptors (NRs) and their transcriptional coregulators.
- Published
- 2008
- Full Text
- View/download PDF
45. Nuclear receptor coregulators and human disease.
- Author
-
Lonard DM, Lanz RB, and O'Malley BW
- Subjects
- Animals, Genetic Diseases, Inborn genetics, Genetic Diseases, Inborn metabolism, Humans, Metabolic Diseases genetics, Metabolic Diseases metabolism, Mice, Repressor Proteins genetics, Syndrome, Trans-Activators genetics, Genetic Diseases, Inborn etiology, Metabolic Diseases etiology, Receptors, Cytoplasmic and Nuclear metabolism, Repressor Proteins physiology, Trans-Activators physiology
- Abstract
Nuclear receptor (NR) coregulators (coactivators and corepressors) are essential elements in regulating nuclear receptor-mediated transcription. In a little more than a decade since their discovery, these proteins have been studied mechanistically and reveal that the regulation of transcription is a highly controlled and complex process. Because of their central role in regulating NR-mediated transcription and in coordinating intercompartmental metabolic processes, disruptions in coregulator biology can lead to pathological states. To date, the extent to which they are involved in human disease has not been widely appreciated. In a complete literature survey, we have identified nearly 300 distinct coregulators, revealing that a great variety of enzymatic and regulatory capabilities exist for NRs to regulate transcription and other cellular events. Here, we substantiate that coregulators are broadly implicated in human pathological states and will be of growing future interest in clinical medicine.
- Published
- 2007
- Full Text
- View/download PDF
46. SLIRP, a small SRA binding protein, is a nuclear receptor corepressor.
- Author
-
Hatchell EC, Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles KM, Redfern AD, Miles LE, Barker A, MacDonald LM, Arthur PG, Lui JC, Golding JL, McCulloch RK, Metcalf CB, Wilce JA, Wilce MC, Lanz RB, O'Malley BW, and Leedman PJ
- Subjects
- Amino Acid Sequence, Animals, Base Sequence, Breast Neoplasms metabolism, COS Cells, Chlorocebus aethiops, Cloning, Molecular, DNA-Binding Proteins, Female, HeLa Cells, Histone Acetyltransferases, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Humans, Mitochondria metabolism, Molecular Sequence Data, Nuclear Proteins genetics, Nuclear Receptor Co-Repressor 1, Nuclear Receptor Coactivator 1, Promoter Regions, Genetic, Protein Conformation, RNA, Long Noncoding, RNA, Untranslated genetics, RNA-Binding Proteins chemistry, RNA-Binding Proteins genetics, Repressor Proteins genetics, Sequence Alignment, Transcription Factors genetics, Transcription Factors metabolism, Tumor Cells, Cultured, Nuclear Proteins metabolism, RNA, Untranslated metabolism, RNA-Binding Proteins metabolism, Repressor Proteins metabolism
- Abstract
Steroid receptor RNA activator (SRA), the only known RNA coactivator, augments transactivation by nuclear receptors (NRs). We identified SLIRP (SRA stem-loop interacting RNA binding protein) binding to a functional substructure of SRA, STR7. SLIRP is expressed in normal and tumor tissues, contains an RNA recognition motif (RRM), represses NR transactivation in a SRA- and RRM-dependent manner, augments the effect of Tamoxifen, and modulates association of SRC-1 with SRA. SHARP, a RRM-containing corepressor, also binds STR7, augmenting repression with SLIRP. SLIRP colocalizes with SKIP (Chr14q24.3), another NR coregulator, and reduces SKIP-potentiated NR signaling. SLIRP is recruited to endogenous promoters (pS2 and metallothionein), the latter in a SRA-dependent manner, while NCoR promoter recruitment is dependent on SLIRP. The majority of the endogenous SLIRP resides in the mitochondria. Our data demonstrate that SLIRP modulates NR transactivation, suggest it may regulate mitochondrial function, and provide mechanistic insight into interactions between SRA, SLIRP, SRC-1, and NCoR.
- Published
- 2006
- Full Text
- View/download PDF
47. Nuclear Receptor Signaling Atlas (www.nursa.org): hyperlinking the nuclear receptor signaling community.
- Author
-
Lanz RB, Jericevic Z, Zuercher WJ, Watkins C, Steffen DL, Margolis R, and McKenna NJ
- Subjects
- Animals, Computational Biology, Gene Expression Profiling, Humans, Internet, Mice, Polymerase Chain Reaction, Receptors, Cytoplasmic and Nuclear chemistry, Receptors, Cytoplasmic and Nuclear genetics, Signal Transduction, Software, Systems Integration, User-Computer Interface, Databases, Protein, Receptors, Cytoplasmic and Nuclear metabolism
- Abstract
The nuclear receptor signaling (NRS) field has generated a substantial body of information on nuclear receptors, their ligands and coregulators, with the ultimate goal of constructing coherent models of the biological and clinical significance of these molecules. As a component of the Nuclear Receptor Signaling Atlas (NURSA)--the development of a functional atlas of nuclear receptor biology--the NURSA Bioinformatics Resource is developing a strategy to organize and integrate legacy and future information on these molecules in a single web-based resource (www.nursa.org). This entails parallel efforts of (i) developing an appropriate software framework for handling datasets from NURSA laboratories and (ii) designing strategies for the curation and presentation of public data relevant to NRS. To illustrate our approach, we have described here in detail the development of a web-based interface for the NURSA quantitative PCR nuclear receptor expression dataset, incorporating bioinformatics analysis which provides novel perspectives on functional relationships between these molecules. We anticipate that the free and open access of the community to a platform for data mining and hypothesis generation strategies will be a significant contribution to the progress of research in this field.
- Published
- 2006
- Full Text
- View/download PDF
48. A scoring system for the follow up study of nuclear receptor coactivator complexes.
- Author
-
Han SJ, Jung SY, Malovannaya A, Kim T, Lanz RB, Qin J, and O'Malley BW
- Abstract
We have systematically isolated a variety of coactivator complexes from HeLa S3 cells using proteomic approaches. In the present report, we have evaluated twelve coactivator complexes involved in nuclear receptor-dependent gene transcription that have been purified by using an immunoprecipitation method. The twelve purified coactivator complexes are SRC-1, SRC-2, SRC-3, CBP, p300, CAPER, E6-AP, ASC-1, CoREST, CRSP3, CRSP2, and CDK7 containing complexes. We have identified 153 protein components associated with these coactivator complexes using mass spectrometry. In order to systematically characterize the functional roles for these components in nuclear receptor-dependent gene transcription and their investigative potential, we have developed a scoring system. This scoring system is comprised of biological and experimental parameters. The biological evaluation considers aspects such as intrinsic enzymatic activity of a protein component, cellular signaling processes in which protein components may be involved, associations with human disease, specific protein motifs, and the known biological roles of other interacting partners of the identified protein. In the experimental evaluation, we include parameters, such as the availability of research materials for the functional study of the identified protein component; such as full-length cDNA clones, antibodies, and commercially available knock-out embryonic stem (ES) cells. Each scoring parameter has been assigned an arbitrary number of points according to perceived relative importance. On the basis of this scoring system, we prioritized each of the protein components in terms of the likelihood of their importance for coactivator complex networking in nuclear receptor-dependent gene transcription.
- Published
- 2006
- Full Text
- View/download PDF
49. Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene.
- Author
-
Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, Lanz RB, Zoumpourlis VC, and Schwartz RJ
- Subjects
- Actins metabolism, Animals, Binding Sites, Cell Differentiation, Cell Line, Cells, Cultured, DNA metabolism, DNA Primers chemistry, Glutathione Transferase metabolism, Humans, Immunoprecipitation, Ligands, Mice, Muscle, Skeletal metabolism, Muscles cytology, Plasmids metabolism, Promoter Regions, Genetic, Protein Binding, Protein Structure, Tertiary, Protein Transport, RNA, Messenger metabolism, Receptors, Androgen metabolism, Time Factors, Transcription, Genetic, Transfection, Receptors, Androgen chemistry, Serum Response Factor metabolism
- Abstract
Androgen receptor (AR) induced precocious myogenesis in culture and myogenic specified gene activity. Increased levels of AR expression in replicating C2C12 myoblasts stimulated fusion into post-differentiated multinucleated myotubes and the appearance of skeletal alpha-actin transcripts, even in the absence of ligand. Furthermore, AR activated the skeletal alpha-actin promoter, which lacks GRE sites, in co-transfected C2C12 cells. AR co-activation of the skeletal alpha-actin promoter required co-expressed full-length serum response factor (SRF). In vitro, AR associated with SRF and was recruited by SRF to a alpha-actin promoter SRF binding site. Our data suggest that AR is capable of activating myogenic genes devoid of consensus AR binding sites via its recruitment by the myogenic enriched transcription factor, SRF.
- Published
- 2005
- Full Text
- View/download PDF
50. SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity.
- Author
-
Coleman KM, Lam V, Jaber BM, Lanz RB, and Smith CL
- Subjects
- Blotting, Western, Cell Line, DNA metabolism, Estrogen Receptor beta metabolism, Gene Deletion, Gene Expression Regulation, HeLa Cells, Humans, Mutation, Phosphorylation, Plasmids metabolism, Protein Structure, Tertiary, RNA, Long Noncoding, RNA, Untranslated metabolism, Transcription, Genetic, Transfection, Drug Resistance, Neoplasm, Estrogen Receptor alpha metabolism, RNA, Untranslated physiology, Tamoxifen agonists, Tamoxifen analogs & derivatives, Tamoxifen pharmacology
- Abstract
The ability of steroid receptor RNA activator (SRA), an AF-1 coactivator, to contribute to differences in estrogen receptor (ER)-alpha and ERbeta transcriptional activity was tested. In transient transfections, SRA expression increased ERalpha- and ERbeta-dependent gene expression. However, when the receptors' amino-terminal A/B regions were examined as GAL4 DNA binding domain fusions, SRA enhanced the activity of GAL-ABalpha but not GAL-ABbeta. Exogenous SRA also enhanced AF-2 activity for both receptors, indicating that SRA effects are not limited to AF-1. Simultaneously mutating three phosphorylation sites within GAL-ABalpha domain only modestly reduced SRA coactivation of GAL-ABalpha, suggesting that phosphorylation does not play a major role in SRA function relative to this domain. SRA enhanced ERalpha activity stimulated by 4-hydroxytamoxifen, but was unable to convert this mixed antiestrogen to an ERbeta agonist. Thus, SRA is an ERalpha AF-1-specific coactivator that enhances the agonist activity of tamoxifen-bound ERalpha and may contribute to tamoxifen resistance., (Copyright 2004 Elsevier Inc.)
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.